NLM Logo

Radioimmunotherapy MeSH Descriptor Data 2024


MeSH Heading
Radioimmunotherapy
Tree Number(s)
E02.095.465.425.750
E02.186.750
E02.815.520
Unique ID
D016499
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016499
Annotation
coordinate with disease /‌radiother
Scope Note
Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
Entry Version
RADIOIMMUNOTHER
Entry Term(s)
Immunoradiotherapy
NLM Classification #
QZ 270
Previous Indexing
Antibodies, Monoclonal/therapeutic use (1984-1991)
Immunotherapy (1984-1991)
specific radioisotope/therapeutic use (1981-1991)
Public MeSH Note
92
History Note
92
Date Established
1992/01/01
Date of Entry
1991/05/02
Revision Date
2009/07/06
Radioimmunotherapy Preferred
page delivered in 0.146s